Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
97%
Blood Plasma
96%
Humoral Immune Deficiency
77%
Systemic Scleroderma
75%
Cytokine
63%
Primary Immunodeficiency
59%
Prevalence
58%
COVID-19
50%
Spike
37%
Common Variable Immunodeficiency
34%
Immunity
33%
T Cell
31%
Immunology
29%
Peripheral Blood Mononuclear Cell
26%
Immunodeficiency
26%
Genetic Screening
25%
Thyroid
25%
Interferon Type I
25%
Immune System
25%
Intravenous Immunoglobulin
24%
B Cell
22%
Immune Response
22%
Interleukin 6
22%
Hereditary Angioedema
21%
Immunity
21%
Light Chain
20%
Chronic Inflammatory Demyelinating Polyneuropathy
20%
Leukocyte
19%
Immunostimulation
18%
Genetic Trait
18%
Autoimmune Hemolytic Anemia
18%
Azathioprine
18%
Idiopathic Thrombocytopenic Purpura
18%
Postcovid Syndrome
18%
Cytokine Response
18%
Atopic Dermatitis
18%
Chronic Urticaria
18%
Telomere
18%
Immunosuppressive Therapy
18%
Telomere Length
18%
Low Drug Dose
18%
Stem Cell Transplantation
18%
Cancer Staging
18%
Pericarditis
18%
Neurofilament
18%
Lymphocyte Subpopulation
18%
Hemophagocytic Lymphohistiocytosis
18%
Cell Membrane
18%
Adoptive Immunity
18%
Tumor Necrosis Factor Alpha
18%
Medicine and Dentistry
Disease
100%
Biological Marker
75%
Hereditary Angioedema
56%
Severe Acute Respiratory Syndrome Coronavirus 2
56%
Neurofilament
46%
Chernobyl Nuclear Power Plant
42%
Primary Immunodeficiency
41%
Light Chain
39%
Humoral Immune Deficiency
37%
Systemic Scleroderma
37%
Chronic Urticaria
37%
Thyroid Disease
37%
Disease Course
37%
Neuropathy
33%
Serum Albumin
31%
Clinical Feature
25%
Thyroid Gland
25%
Prevalence
22%
COVID-19 Vaccination
22%
Polyneuropathy
22%
Infection
21%
Patient Care
21%
Immunity
21%
Disease Exacerbation
20%
Chronic Inflammatory Demyelinating Polyneuropathy
20%
Pericarditis
18%
Idiopathic Thrombocytopenic Purpura
18%
Vaccination Coverage
18%
Cytokine Response
18%
Stem Cell Therapy
18%
Immunostimulation
18%
Vaccine Hesitancy
18%
Evans Syndrome
18%
Hypocomplementemia
18%
Genetic Trait
18%
Immunosuppressive Treatment
18%
Immunological Memory
18%
Azathioprine
18%
Hemophagocytic Lymphohistiocytosis Syndrome
18%
Immune Deficiency
18%
Cohort Effect
18%
Peripheral Blood Mononuclear Cell
18%
Electron Spin Resonance
18%
Cell Membrane
18%
Multifocal Motor Neuropathy
18%
Ferric Ion
18%
Kennedy Disease
18%
Patient Monitoring
18%
Hemophagocytic Syndrome
18%
Ferrous Ion
18%
Pharmacology, Toxicology and Pharmaceutical Science
Ionizing Radiation
60%
Disease
45%
Angioneurotic Edema
40%
Prevalence
39%
Serum Albumin
37%
Systemic Sclerosis
37%
Immunoglobulin
28%
Clinical Feature
25%
Polyneuropathy
22%
Neuropathy
20%
Motor Neuropathy
18%
Hypocomplementemia
18%
Ferrous Ion
18%
Chronic Urticaria
18%
Biological Marker
18%
SARS Coronavirus
18%
Myasthenia gravis
18%
Cytokine
18%
Ferric Ion
18%
Thyroid Disease
18%
Interferon
18%
Disease Course
18%
Chronic Inflammatory Demyelinating Polyneuropathy
18%
Immunosuppressive Agent
18%
Azathioprine
18%
Idiopathic Thrombocytopenic Purpura
18%
Autoimmune Hemolytic Anemia
18%
Inflammation
18%
Radiation Exposure
18%
Autoimmune Disease
16%
Immune Deficiency
15%
Rheumatoid Arthritis
14%
Multiple Sclerosis
14%
Biological Target
14%
Inflammatory Arthritis
14%
Infection
13%
Malignant Neoplasm
13%
Hypertransaminasemia
12%
Isoetarine
12%
Glycoprotein
12%
Methylprednisolone
12%
Rituximab
12%
Cyclophosphamide
12%
Isoniazid
11%
Occupational Disease
9%
Erythrocytosis
9%
Oxidizing Agent
9%
Health Status
9%
CD3 Antigen
9%
CD8 Antigen
9%